These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
712 related articles for article (PubMed ID: 24371132)
1. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital]. Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study. Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148 [TBL] [Abstract][Full Text] [Related]
4. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy. Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248 [TBL] [Abstract][Full Text] [Related]
5. Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy. Poolos NP; Castagna CE; Williams S; Miller AB; Story TJ Epilepsy Behav; 2017 Apr; 69():59-68. PubMed ID: 28235655 [TBL] [Abstract][Full Text] [Related]
6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
7. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome). Donaldson JA; Glauser TA; Olberding LS Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186 [TBL] [Abstract][Full Text] [Related]
8. [Lamotrigine add-on therapy for childhood-onset refractory epilepsy: comparison of the efficacy between 3 months and 6 months after initiation]. Watanabe K; Kobayashi K; Endoh F; Yoshinaga H; Ohtsuka Y No To Hattatsu; 2011 Nov; 43(6):453-8. PubMed ID: 22180960 [TBL] [Abstract][Full Text] [Related]
9. Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis. Aberg LE; Bäckman M; Kirveskari E; Santavuori P Epilepsia; 2000 Oct; 41(10):1296-302. PubMed ID: 11051125 [TBL] [Abstract][Full Text] [Related]
10. Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Evans BK; Kustra RP; Hammer AE Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513 [TBL] [Abstract][Full Text] [Related]
11. Conversion from immediate-release to extended-release lamotrigine improves seizure control. Ramey P; Osborn M; Abou-Khalil B Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163 [TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069 [TBL] [Abstract][Full Text] [Related]
20. Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy. Cocito L; Maffini M; Loeb C Epilepsy Res; 1994 Oct; 19(2):123-7. PubMed ID: 7843167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]